221 related articles for article (PubMed ID: 29788081)
1. Proteomic Characterization of the Extracellular Matrix of Human Uterine Fibroids.
Jamaluddin MFB; Nahar P; Tanwar PS
Endocrinology; 2018 Jul; 159(7):2656-2669. PubMed ID: 29788081
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Profiling of Human Uterine Fibroids Reveals Upregulation of the Extracellular Matrix Protein Periostin.
Jamaluddin MFB; Ko YA; Kumar M; Brown Y; Bajwa P; Nagendra PB; Skerrett-Byrne DA; Hondermarck H; Baker MA; Dun MD; Scott RJ; Nahar P; Tanwar PS
Endocrinology; 2018 Feb; 159(2):1106-1118. PubMed ID: 29244110
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Biol Reprod; 2013 Dec; 89(6):150. PubMed ID: 24174578
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Periostin Expression on Fibroid-Like Transition of Myometrial Cells.
Lenis YY; George JW; Lind S; Balboula A; Teixeira JM; Patterson AL
Reprod Sci; 2023 May; 30(5):1616-1624. PubMed ID: 36418534
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
8. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
[TBL] [Abstract][Full Text] [Related]
9. Modelling fibroid pathology: development and manipulation of a myometrial smooth muscle cell macromolecular crowding model to alter extracellular matrix deposition.
Winter A; Salamonsen LA; Evans J
Mol Hum Reprod; 2020 Jul; 26(7):498-509. PubMed ID: 32449756
[TBL] [Abstract][Full Text] [Related]
10. Interactome Analysis of the Differentially Expressed Proteins in Uterine Leiomyoma.
Sahar T; Nigam A; Anjum S; Waziri F; Biswas S; Jain SK; Wajid S
Anticancer Agents Med Chem; 2019; 19(10):1293-1312. PubMed ID: 30727917
[TBL] [Abstract][Full Text] [Related]
11. SWATH mass spectrometry as a tool for quantitative profiling of the matrisome.
Krasny L; Bland P; Kogata N; Wai P; Howard BA; Natrajan RC; Huang PH
J Proteomics; 2018 Oct; 189():11-22. PubMed ID: 29501709
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
Islam MS; Afrin S; Singh B; Jayes FL; Brennan JT; Borahay MA; Leppert PC; Segars JH
Clin Transl Med; 2021 Jul; 11(7):e475. PubMed ID: 34323413
[TBL] [Abstract][Full Text] [Related]
13. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium.
Vollenhoven BJ; Herington AC; Healy DL
J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390
[TBL] [Abstract][Full Text] [Related]
14. RISING STARS: Role of MED12 mutation in the pathogenesis of uterine fibroids.
Ishikawa H; Kobayashi T; Kaneko M; Saito Y; Shozu M; Koga K
J Mol Endocrinol; 2023 Nov; 71(4):. PubMed ID: 37668348
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome.
Barron L; Khadka S; Schenken R; He L; Blenis J; Blagg J; Chen SF; Tsai KL; Boyer TG
F S Sci; 2021 Nov; 2(4):383-395. PubMed ID: 35559861
[TBL] [Abstract][Full Text] [Related]
16. Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition.
Carrino DA; Mesiano S; Barker NM; Hurd WW; Caplan AI
Biochem J; 2012 Apr; 443(2):361-8. PubMed ID: 22257180
[TBL] [Abstract][Full Text] [Related]
17. A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma.
Ura B; Scrimin F; Arrigoni G; Franchin C; Monasta L; Ricci G
Int J Mol Sci; 2016 Apr; 17(4):540. PubMed ID: 27070597
[TBL] [Abstract][Full Text] [Related]
18. The Epidemiology and Genetics of Uterine Leiomyoma.
Styer AK; Rueda BR
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():3-12. PubMed ID: 26725703
[TBL] [Abstract][Full Text] [Related]
19. Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.
Cox J; Malik M; Britten J; Lewis T; Catherino WH
Reprod Sci; 2018 Feb; 25(2):198-206. PubMed ID: 28929861
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical significance of co-existing mutations in
Jamaluddin MFB; Nagendra PB; Ko YA; Bajwa P; Scott RJ; Nahar P; Tanwar PS
Front Reprod Health; 2023; 5():1081092. PubMed ID: 37113812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
